logo-loader
AIM:TRX

Tissue Regenix Group PLC

Receive alerts
Market:
AIM
Price
-
Day Change
-
Market Cap:
-
52 weeks high
-
52 weeks low
-

In brief

Tissue Regenix Group PLC is a pioneering, international medical technology company, focusing on the development of regenerative products utilising its two platform technologies, dCELL, addressing soft tissue needs, and BioRinse, providing sterile bone allografts.

The company is currently helping to transform the treatment of patients in key surgical applications: biosurgery, orthopaedics (sports medicine/spine), dental, general, plastic surgery, urology/gynaecology, ophthalmology and cardiac.